Skip Navigation

AIDSInfo-at-a-glance

Issue No. 22 | May 15, 2009
A Service of the U.S. Department of Health and Human ServicesView HTML version
News and Features 

HIV Vaccine Awareness Day 2009

May 18, 2009, marks the 12th annual observance of HIV Vaccine Awareness Day. HIV Vaccine Awareness Day is dedicated to recognizing HIV vaccine research efforts and educating communities about the importance of developing an HIV vaccine. 

More information is available:

Asian and Pacific Islander HIV/AIDS Awareness Day 2009

May 19, 2009, marks the fifth annual National Asian and Pacific Islander (API) HIV/AIDS Awareness Day. This day is dedicated to increasing awareness of HIV/AIDS in the API community. The goals of National API HIV/AIDS Awareness Day are to educate the API community about HIV/AIDS and its transmission, to promote HIV testing, to motivate HIV-infected APIs to seek proper treatment, and to encourage people to get involved in their communities and combat HIV-related stigmas and discrimination.

More information is available:

HHS to Award $1.79 Billion for People Living with HIV/AIDS

"The U.S. Department of Health and Human Services (HHS) today announced the release of $1.79 billion to ensure that people living with HIV/AIDS continue to have access to life-saving health care and medications. The grants are funded through the Ryan White HIV/AIDS Program, which helps more than 529,000 individuals every year obtain the care and services they need to live longer, healthier lives."

Study: Timing of HAART Predicts B-Cell Response Longevity in HIV-Infected Infants

"Initiation of HAART within the 1st year of life permits the normal development and maintenance of the memory B cell compartment. On the contrary, memory B cells from patients treated later in time are remarkably reduced and their function is compromised regardless of viral control. A cause for concern is that both late-treated HIV-1 controllers and noncontrollers loose [sic] protective antibody titers against common vaccination antigens. Timing of HAART initiation is the major factor predicting the longevity of B cell responses in vaccinated HIV-1-infected children."

Home | Guidelines | Clinical Trials | Drugs | Health Topics | Education Materials | Mobile Resources & Tools
Unsubscribe | Contact Us
Left footer corner image Left footer corner image